EU Panel OKs Aflibercept for Diabetic Macular Edema (Eylea)EU Panel OKs Aflibercept for Diabetic Macular Edema (Eylea)

The company marketing the drug in the United States has asked the US Food and Drug Administration to add this indication as well. International Approvals
Source: Medscape Ophthalmology Headlines - Category: Opthalmology Tags: Ophthalmology News Alert Source Type: news